(855) 426-6284

A radiation treatment specifically designed for use inside the brain, GammaTile Therapy gives patients new hope in the fight against brain tumors. It can eliminate the need for traditional repeat radiation treatments and associated hospital or clinic visits, so patients can focus on what matters most—healing.

Get a head STaRT in the fight against brain tumors

Improved local tumor control in patients with recurrent meningiomas and recurrent brain metastases

MENINGIOMA PATIENTS RECURRENCE FREE AT 2 YEARS[2]

BRAIN METASTASES PATIENTS RECURRENCE FREE AT 1 YEAR[3]

RECURRENT GBM PATIENTS MEDIAN OVERALL SURVIVAL[4,5]

Potential to extend overall survival in patients with recurrent glioblastoma

REFERENCES

  1. Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: Safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35-S3
  2. Rogers L, Nakaji P, Youssef E, et al. Resection and surgically targeted radiation therapy for initial salvage treatment of aggressive meningioma: results from a prospective trial. Presented at: CNS 2020 Virtual Conference; September 30, 2020.
  3. Brachman, D, Nakaji, P, et al. A prospective trial of resection plus surgically targeted radiation therapy for brain metastasis. Poster presented at: SNO 2020 Virtual Conference on Brain Metastases; August 14, 2020.
  4. Data on file, GT Medical Technologies, Inc.
  5. Tsien C, Pugh S, Dicker AP, et al. Randomized phase II trial of re-irradiation and concurrent bevacizumab versus bevacizumab alone as treatment for recurrent glioblastoma (NRG Oncology/RTOG 1205): initial outcomes and RT plan quality report. International Journal of Radiation Oncology, Biology, Physics. 2019; 105(1):578.

Patient Experience Video | September 11, 2019 | Joan, a survivor of a meningioma treated with GammaTile Therapy

Patient Experience Video | December 19, 2019 | Shannan, a recurrent glioma survivor.

Patient Experience Video | July 15, 2021 l Robert, a survivor of a metastatic brain tumor. 

Patient Perspectives

Learn More About GammaTile Therapy
© 2___ GT Medical Technologies, Inc. All rights reserved.
Document #: MKT-081-1
TREATMENT CONSIDERATIONS
GammaTile Therapy is intended to deliver radiation therapy in patients with newly diagnosed malignant brain tumors and recurrent brain tumors. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.
(855) 426-6284

Tough on Brain Tumors

Easier on Patients and Caregivers

FIND OUT IF GAMMATILE IS RIGHT FOR YOU

Clinical Outcomes

For patients with recurrent meningiomas and recurrent brain metastases, the use of GammaTile Therapy demonstrated a significant delay in treatment site recurrence compared to their previous treatments. [2,3]

GammaTile Therapy demonstrates a potential for improved|overall survival when comparing the effectiveness of surgery plus GammaTile Therapy to other treatment modalities across different clinical studies in patients with recurrent glioblastoma (GBM).

Everything you need to start the conversation with your doctor.

Download Our Patient Education Pamphlet Today